Training activity information
Details
Using representative patient samples from a range of tissue types, with a consultant supervisor identify the following processes:
- Metaplasia
- Dysplasia
- Malignancy
- Metastasis
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Role of the patient history in developing the clinical picture
- Implications for patient pathways
- Differences between the types of pathological processes
- Macroscopic vs microscopic identification
- Microscopical differences between normal tissue morphology and tissue undergoing these processes
- Local SOPs
- Specimen block sampling and macroscopic description
- Quality of blocks
- RCPath tissue pathways and cancer datasets
- Screening programmes
- Selection of histochemical, immunohistochemical, and molecular techniques to demonstrate different cell types involved these pathological processes
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 6 |
Outcome
Use histological techniques to demonstrate the different types of abnormal proliferation. |
| # 9 |
Outcome
Practice safely in accordance with quality management and accreditation standards. |